Cell Growth & Differentiation, Vol 8, Issue 4 371-380, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factors

W Clark and DA Gillespie
Beatson Institute for Cancer Research, Cancer Research Campaign Beatson Laboratories, Bearsden, Glasgow, United Kingdom.

To gain insight into the mechanism of action of the v-Jun oncoprotein, we compared the growth and cell cycle behavior of normal and v-Jun-transformed fibroblasts. We show that v-Jun induces marked alterations in cell cycle regulation in both the presence and absence of serum growth factors. During asynchronous growth, v-Jun-transformed fibroblasts divide more rapidly than their normal counterparts, owing to a reduction in the length of the G1 phase of the cell cycle. When deprived of serum mitogens, normal fibroblasts exit the cycle and enter a reversible state of quiescence (G0). In contrast, v-Jun-transformed fibroblasts continue to cycle and maintain increased levels of retinoblastoma tumor suppressor protein phosphorylation and elevated expression of cell cycle-dependent markers such as cyclin A, cyclin-dependent protein kinase 2 (CDK2), and CDC2. v-Jun-transformed fibroblasts nevertheless remain wholly dependent on growth factors for cell multiplication, because cell cycle progression in the absence of serum is accompanied by high rates of apoptotic cell death. We conclude that v-Jun shares the capacity of the Myc, E1A, and E2F oncoproteins to promote both cell cycle progression and apoptosis under conditions of mitogen depletion.

This article has been cited by other articles:

				S. V. Sharma and J. Settleman Oncogene addiction: setting the stage for molecularly targeted cancer therapy Genes & Dev., December 15, 2007; 21(24): 3214 - 3231. [Abstract] [Full Text] [PDF]

				A. MacLaren, E. J. Black, W. Clark, and D. A. F. Gillespie c-Jun-Deficient Cells Undergo Premature Senescence as a Result of Spontaneous DNA Damage Accumulation Mol. Cell. Biol., October 15, 2004; 24(20): 9006 - 9018. [Abstract] [Full Text] [PDF]

				M. Werner-Washburne, B. Wylie, K. Boyack, E. Fuge, J. Galbraith, J. Weber, and G. Davidson Comparative Analysis of Multiple Genome-Scale Data Sets Genome Res., October 1, 2002; 12(10): 1564 - 1573. [Abstract] [Full Text] [PDF]

				D. B. Parkinson, Z. Dong, H. Bunting, J. Whitfield, C. Meier, H. Marie, R. Mirsky, and K. R. Jessen Transforming Growth Factor beta (TGFbeta ) Mediates Schwann Cell Death In Vitro and In Vivo: Examination of c-Jun Activation, Interactions with Survival Signals, and the Relationship of TGFbeta -Mediated Death to Schwann Cell Differentiation J. Neurosci., November 1, 2001; 21(21): 8572 - 8585. [Abstract] [Full Text] [PDF]

				W. Clark, E. J. Black, A. MacLaren, U. Kruse, N. LaThangue, P. K. Vogt, and D. A. F. Gillespie v-Jun Overrides the Mitogen Dependence of S-Phase Entry by Deregulating Retinoblastoma Protein Phosphorylation and E2F-Pocket Protein Interactions as a Consequence of Enhanced Cyclin E-cdk2 Catalytic Activity Mol. Cell. Biol., April 1, 2000; 20(7): 2529 - 2542. [Abstract] [Full Text]

				A. Kilbey, V. Stephens, and C. Bartholomew Loss of Cell Cycle Control by Deregulation of Cyclin-dependent Kinase 2 Kinase Activity in Evi-1 Transformed Fibroblasts Cell Growth Differ., September 1, 1999; 10(9): 601 - 610. [Abstract] [Full Text]